Comparison of dual-antiplatelet therapy durations after endovascular revascularization of infrainguinal arteries

Annals of Vascular Surgery

Volumn 29, Issue 6, 2015, Pages 1235-1244

  Sarode, Karan ^a,b   Mohammad, Atif ^a,b   Das, Swagata ^a   Vinas, Ariel ^b   Banerjee, Avantika ^a   Tsai, Shirling ^a,b   Armstrong, Ehrin J ^c   Shammas, Nicolas W ^d   Klein, Andrew ^e   Brilakis, Emmanouil S ^a,b   Banerjee, Subhash ^a,b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Health Care System   (United States)

^d MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^e S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL; TICAGRELOR; WARFARIN; ANTITHROMBOCYTIC AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG WITHDRAWAL; DUAL ANTICOAGULANT THERAPY; ENDOVASCULAR REVASCULARIZATION; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT THROMBOSIS; SURVIVAL; SURVIVAL RATE; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR STENT; ADVERSE EFFECTS; AGE; AGED; AMPUTATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMORBIDITY; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; KAPLAN MEIER METHOD; LIMB SALVAGE; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TRENDS; UNITED STATES;

AGE FACTORS; AGED; AMPUTATION; COMORBIDITY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; ENDOVASCULAR PROCEDURES; FEMALE; HEMORRHAGE; HUMANS; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; PRACTICE PATTERNS, PHYSICIANS'; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84938967047     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2015.03.040     Document Type: Article

References (38)

1. M. Schillinger, and E. Minar Percutaneous treatment of peripheral artery disease: novel techniques Circulation 126 2012 2433 2440
2. P. Sobieszczyk, and A. Eisenhauer Management of patients after endovascular interventions for peripheral artery disease Circulation 128 2013 749 757
3. F. Violi, S. Basili, J.S. Berger, and et al. Antiplatelet therapy in peripheral artery disease Handb Exp Pharmacol 2012 547 563
4. L. Norgren, W.R. Hiatt, J.A. Dormandy, et al. TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
5. M.W. Mewissen Primary nitinol stenting for femoropopliteal disease J Endovasc Ther 16 2009 II63 81
6. M.T. Allemang, R.R. Rajani, P.R. Nelson, and et al. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures Ann Vasc Surg 27 2013 62 67
7. K. Sarode, O.F. Hadidi, R. Thomas, and et al. TCT-523 Multicenter Registry for Peripheral Arterial Disease Interventions and Outcomes (XLPAD Registry) J Am Coll Cardiol 62 2013 B158
8. P.A. Harris, R. Taylor, R. Thielke, and et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support J Biomed Inform 42 2009 377 381
9. S. Banerjee, T.S. Das, M.S. Abu-Fadel, and et al. Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: the COBRA trial J Am Coll Cardiol 60 2012 1352 1359
10. D. Kandzari, S. Sigmund, S. Windecker, and et al. Pharmacodynamic considerations and clinical impact of dual antiplatelet therapy interruption after resolute zotarolimus-eluting stent implantation J Am Coll Cardiol 63 2014
11. M.D. Dake, G.M. Ansel, M.R. Jaff, and et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies J Am Coll Cardiol 61 2013 2417 2427
12. S.R. Mehta, S. Yusuf, R.J. Peters, and et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
13. S.R. Steinhubl, P.B. Berger, J.T. Mann, and et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial J Am Med Assoc 288 2002 2411 2420
14. S.D. Wiviott, E. Braunwald, C.H. McCabe, and et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
15. L. Wallentin, R.C. Becker, A. Budaj, and et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
16. E.S. Brilakis, V.G. Patel, and S. Banerjee Medical management after coronary stent implantation: a review J Am Med Assoc 310 2013 189 198
17. C.W. Lee, J.M. Ahn, D.W. Park, and et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial Circulation 129 2014 304 312
18. F.F. Strobl, K. Brechtel, J. Schmehl, and et al. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease J Endovasc Ther 20 2013 699 706
19. M. Henry, M. Amor, A. Cragg, and et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system Radiology 201 1996 717 724
20. M. Brodmann, P. Rief, H. Froehlich, and et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial Cardiovasc Intervent Radiol 36 2013 69 74
21. T. Jahnke, S. Mueller-Huelsbeck, N. Charalambous, and et al. Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study J Vasc Interv Radiol 21 2010 186 194
22. M.L. Diaz, F. Urtasun, J. Barberena, and et al. Cryoplasty versus conventional angioplasty in femoropopliteal arterial recanalization: 3-year analysis of reintervention-free survival by treatment received Cardiovasc Intervent Radiol 34 2011 911 917
23. H. Krankenberg, M. Schluter, H.J. Steinkamp, and et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292
24. T. Zeller, C. Tiefenbacher, H.J. Steinkamp, and et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT) J Endovasc Ther 15 2008 390 398
25. M. Schillinger, S. Sabeti, P. Dick, and et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting Circulation 115 2007 2745 2749
26. J.R. Laird, B.T. Katzen, D. Scheinert, and et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
27. S.H. Duda, M. Bosiers, J. Lammer, and et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial J Endovasc Ther 13 2006 701 710
28. D. Scheinert, K. Katsanos, T. Zeller, and et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial J Am Coll Cardiol 60 2012 2290 2295
29. M. Bosiers, D. Scheinert, P. Peeters, and et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease J Vasc Surg 55 2012 390 398
30. G. Tepe, T. Zeller, T. Albrecht, and et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
31. F. Liistro, S. Grotti, I. Porto, and et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery) J Am Coll Cardiol Interv 6 2013 1295 1302
32. M. Werk, S. Langner, B. Reinkensmeier, and et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
33. D. Scheinert, S. Duda, T. Zeller, and et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty J Am Coll Cardiol Interv 7 2014 10 19
34. M. Werk, T. Albrecht, D.R. Meyer, and et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 2012 831 840
35. F. Liistro, I. Porto, P. Angioli, and et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia Circulation 128 2013 615 621
36. M.P. Bonaca, B.M. Scirica, M.A. Creager, and et al. Vorapaxar in patients with peripheral artery disease: results from TRA2P-TIMI 50 Circulation 127 2013 1522 1529
37. S. Anand, S. Yusuf, C. Xie, and et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease N Engl J Med 357 2007 217 227
38. th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e669S e690S